Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma-Reference-Cited by-同舟云学术

Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma

Published:2021-06-23 Issue:11 Volume:56 Page:2664-2671
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Lemieux Christopher,Muffly Lori S.^ORCID,Iberri David J.,Craig Juliana K.^ORCID,Johnston Laura J.,Lowsky Robert,Shiraz Parveen^ORCID,Rezvani Andrew R.,Frank Matthew J.,Weng Wen-Kai,Meyer Everett,Shizuru Judith A.^ORCID,Arai Sally,Liedtke Michaela,Negrin Robert S.,Miklos David B.,Sidana Surbhi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01371-1.pdf

Reference45 articles.

1. Palumbo A, Bringhen S, Ludwig H, Dimopoulos MA, Blade J, Mateos MV, et al. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood. 2011;118:4519–29. https://doi.org/10.1182/blood-2011-06-358812.

2. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27:2758–65. https://doi.org/10.1200/JCO.2008.20.8983.

3. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N. Engl J Med. 1996;335:91–7. https://doi.org/10.1056/NEJM199607113350204.

4. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N. Engl J Med. 2003;348:1875–83. https://doi.org/10.1056/NEJMoa022340.

5. Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95:548–67. https://doi.org/10.1002/ajh.25791.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of second salvage autologous transplantation in myeloma patients;Pathology and Oncology Research;2024-07-16

2. Multiple Myeloma;Comprehensive Hematology and Stem Cell Research;2024

3. Upfront or Deferred Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Triplet and Quadruplet Induction and Minimal Residual Disease/Risk-Adapted Therapy;Cancers;2023-12-05

4. Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?;Hematology/Oncology Clinics of North America;2023-12

5. Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care;Annals of Hematology;2023-10-25